Sensome develops micro-sensor systems for medical devices which exploit impedance together with machine learning algorithms to reliably identify biological tissues.

Sensome, a France-based medtech device sensor spinout from École Polytechnique, received €4.6m ($5.4m) yesterday in a round featuring spinout-focused venture capital vehicle Paris-Saclay Seed Fund.

Venture capital firm Kurma Partners led the round, investing together with financial services firm BNP Paribas’s investment arm, BNP Paribas Développement, VC firm Idinvest and undisclosed additional investors.

Paris-Saclay Seed Fund launched in January 2017 with $53m in funding for spinouts of Paris-Saclay University.

Sensome develops micro-sensor systems for medical devices which exploit impedance…